Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Celtrix Pharmaceuticals Inc.

Division of Insmed Inc.

Latest From Celtrix Pharmaceuticals Inc.

Elan's Response to FASB

While the Federal Accounting Standards Board has basically ruled out the kinds of limited partnerships Elan for years used to finance its R&D off its income statement, a new set of deals show just how Elan is using deals with biotechs and other drug delivery companies to both supplement its research program and spare its P&L.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Insmed Inc.
  • Senior Management
  • Andreas Sommer, PhD, Pres. & CEO
    Donald D Huffman, VP, Fin. & Admin. & CFO
    Bruce A Riddell, VP, Mktg. & Sales
    David M Rosen, PhD, VP, R&D
    Malcolm J McKay, VP, Reg. Affairs & Qual. Assurance
  • Contact Info
  • Celtrix Pharmaceuticals Inc.
    Phone: (408) 988-2500
    2033 Gateway Place, #600
    San Jose , CA 95110-1002